← Every applicant

Piramal FDA Approvals

4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDENew drugMay 14, 2025TABLET, ORAL
VARENICLINE TARTRATENew drugJul 23, 2024TABLET, ORAL
RANOLAZINENew drugJul 25, 2023TABLET, EXTENDED RELEASE, ORAL
CISATRACURIUM BESYLATENew drugMar 11, 2022INJECTABLE, INJECTION

Related datasets